Soyoko Morimoto

J-GLOBAL         Last updated: Nov 6, 2019 at 12:58
 
Avatar
Name
Soyoko Morimoto

Research Areas

 
 

Published Papers

 
Morimoto S, Fujiki F, Kondo K, Nakajima H, Kobayashi Y, Inatome M, Aoyama N, Nishida Y, Tsuboi A, Oka Y, Nishida S, Nakata J, Hosen N, Oji Y, Sugiyama H
Oncotarget   9(75) 34132-34141   Sep 2018   [Refereed]
Nishida S, Tsuboi A, Tanemura A, Ito T, Nakajima H, Shirakata T, Morimoto S, Fujiki F, Hosen N, Oji Y, Kumanogoh A, Kawase I, Oka Y, Azuma I, Morita S, Sugiyama H
Medicine   98(33) e16771   Aug 2019   [Refereed]
Nakata J, Nakae Y, Kawakami M, Morimoto S, Motooka D, Hosen N, Fujiki F, Nakajima H, Hasegawa K, Nishida S, Tsuboi A, Oji Y, Oka Y, Kumanogoh A, Sugiyama H
British journal of haematology   182(2) 287-290   Jul 2018   [Refereed]
Tsuboi A, Hashimoto N, Fujiki F, Morimoto S, Kagawa N, Nakajima H, Hosen N, Nishida S, Nakata J, Morita S, Sakamoto J, Oji Y, Oka Y, Sugiyama H
Cancer immunology, immunotherapy : CII   68(2) 331-340   Feb 2019   [Refereed]
Versteven M, Van den Bergh JMJ, Broos K, Fujiki F, Campillo-Davo D, De Reu H, Morimoto S, Lecocq Q, Keyaerts M, Berneman Z, Sugiyama H, Van Tendeloo VFI, Breckpot K, Lion E
Oncotarget   9(45) 27797-27808   Jun 2018   [Refereed]

Conference Activities & Talks

 
Establishment of a novel platform cell line for efficient and precise evaluation of T cell receptor functional avidity and its application
Soyoko Morimoto
International conference on WT1 biology   19 May 2019   
Establishment of a novel platform cell line for efficient and precise evaluation of T cell receptor functional avidity
Soyoko Morimoto
The 9th International Conference on WT1 in human neoplasia   29 Jun 2018   
Control of measurement uncertainty in WT1-tetramer assay ―Our experience in WT1 peptide-based immunotherapy―
Soyoko Morimoto
The 8th International Conference on WT1 in human neoplasia   19 Nov 2015   
A correlation between WT1-specific immune responses and clinical efficacy in WT1-peptide vaccinated patients
Soyoko Morimoto
The 7th International Conference on WT1 in human neoplasia   22 Apr 2014   
Biased usage of T cell receptor b-chain variable region genes of WT1-specific CD8+ Tcells in patients with solid tumors and healthy donors
Soyoko Morimoto
5 Dec 2012